Correlation of alternative splicing of the D2 dopamine receptor mRNA and estrogen receptor mRNA in the prolactinomas and gonadotrope tumors

Journal of Neuro-Oncology

Volumn 94, Issue 1, 2009, Pages 135-139

  Wu, Zhe Bao ^a,b   Li, Chu Zhong ^a   Zong, Xu Yi ^a   Su, Zhi Peng ^b   Zeng, Yan Jun ^c   Zhang, Ya Zhuo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Dopamine 2 receptor isoforms; Estrogen receptor isoforms; Gonadotrope adenoma; Prolactinoma

Indexed keywords

DOPAMINE 2 RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GONADOTROPH ADENOMA; HUMAN; MALE; PROLACTINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ALTERNATIVE SPLICING; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTINOMA; PROTEIN ISOFORMS; RECEPTORS, DOPAMINE D2; RECEPTORS, ESTROGEN; RNA, MESSENGER; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 67650475410     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9816-5     Document Type: Article

References (24)

1. Friend KE, Chiou YK, Lopes MBS, Laws ER Jr, Hughes KM, Shupnik MA (1994) Estrogen receptor expression in human pituitary: Correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 78:1497-1504. doi: 10.1210/jc.78.6.1497
2. Zafar M, Ezzat S, Raymyar L, Pan N, Smyth HS, Asa SL (1995) Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 80:3621-3627. doi: 10.1210/ jc.80.12.3621
3. Chaidarun SS, Klibanski A, Alexander JM (1997) Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. J Clin Endocrinol Metab 82:1058-1065. doi: 10.1210/jc.82.4.1058
4. Pinchon MF, Bression D, Peillon F, Milgrom E (1980) Estrogen receptors in human pituitary adenomas. J Clin Endocrinol Metab 51:897-902
5. Shupnik MA, Pitt LK, Soh AY, Anderson A, Lopes MB, Laws ER Jr (1998) Selective expression of estrogen receptor α and β isoforms in human pituitary tumors. J Clin Endocrinol Metab 83:3965-3972. doi: 10.1210/jc.83.11.3965
6. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930. doi: 10.1073/pnas.93.12.5925
7. Pettersson K, Grandien K, Kuiper GGJM, Gustafsson J-A (1997) Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 11:1486-1496. doi: 10.1210/me.11.10.1486
8. Mitchner NA, Garlick C, Ben-Jonathan N (1998) Cellular distribution and gene regulation of estrogen receptors α and β in the rat pituitary gland. Endocrinology 139:3976-3983. doi: 10.1210/en.139.9.3976
9. Albert PR (2002) G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH(4) pituitary cells. Mol Endocrinol 16:1903-1911. doi: 10.1210/me.2001-0329
10. Montmayeur JP, Guiramand J, Borrelli E (1993) Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endocrinol 7:161-170. doi: 10.1210/me.7.2.161
11. Senogles SE (1994) The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. J Biol Chem 269:23120-23127
12. Wolfe SE, Morris SJ (1999) Dopamine D2 receptor isoforms expressed in AtT20 cells differentially couple to G proteins to acutely inhibit high voltage-activated calcium channels. J Neurochem 73:2375-2382. doi: 10.1046/j.1471-4159.1999.0732375.x
13. Oomizu S, Boyadjieva N, Sarkar DK (2003) Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland. Alcohol Clin Exp Res 27(6):975-980
14. Sarkar DK, Gottschall PE, Meites J (1982) Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting pituitary tumors. Science 218:684-686. doi: 10.1126/ science.7134966
15. Raymond V, Beaulieu M, Labrie F (1978) Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 200:1173-1175. doi: 10.1126/science.418505
16. Horvath E, Kovacs K (1991) The adenohypophysis. In: Kovacs K, Asa SL (eds) Functional endocrine pathology. Blackwell, Boston, pp 245-281
17. Chaidrun SS, Swearingen B, Alexander JM (1998) Differential expression of estrogen receptor-beta (ER-beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant. J Clin Endocrinol Metab 83:3308-3315. doi: 10.1210/jc.83.9.3308
18. Caccavelli L, Feron F, Morange I, Rouer E, Benarous R, Dewailly D (1994) Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas. Neruoendocrinology 60:314-322. doi: 10.1159/000126764
19. Guivarc'h D, Vincent JD, Vernier P (1998) Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line. Endocrinology 139:4213-4221. doi: 10.1210/en.139.10.4213
20. Radl DB, Zarate S, Jaita G, Ferraris J, Zaldivar V, Eijo G, Seilicovich A, Pisera D (2008) Apoptosis of lactotrophs induced by D2 receptor activation is estrogen dependent. Neuroendocrinology 88(1):43-52. doi: 10.1159/000116117
21. Laccarino C, Samad TK, Mathis C, Kercret H, Picetti R, Borrelli E (2002) Control of lactotrope proliferation by dopamine: Essential role of signaling through D2 receptors ERKs. Proc Natl Acad Sci USA 99:14530-14535. doi: 10.1073/pnas.222319599
22. Vidal S, Stefaneanu L, Kovacs K, Yamada S, Bartke A (1999) Pituitary estrogen receptor alpha and dopamine subtype 2 receptor gene expression in transgenic mice with overproduction of heterologous growth hormones. Histochem Cell Biol 111(3):235-241. doi: 10.1007/s004180050353
23. Livingstone JD, Lerant A, Freeman ME (1998) Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes. Neuroendocrinology 68:172-179. doi: 10.1159/000054363
24. Lamberts SWJ (1985) Interactions of steroids with prolactin secretion in vitro. Horm Res 22:172-178. doi: 10.1159/000180091